HRP970473B1 - 6-0-substituted ketolides having antibacterial activity - Google Patents

6-0-substituted ketolides having antibacterial activity

Info

Publication number
HRP970473B1
HRP970473B1 HR970473A HRP970473A HRP970473B1 HR P970473 B1 HRP970473 B1 HR P970473B1 HR 970473 A HR970473 A HR 970473A HR P970473 A HRP970473 A HR P970473A HR P970473 B1 HRP970473 B1 HR P970473B1
Authority
HR
Croatia
Prior art keywords
substituted
alkyl
aryl
heteroaryl
group
Prior art date
Application number
HR970473A
Other languages
English (en)
Croatian (hr)
Inventor
Sun Or Yat
T. Chu Daniel
Ma Zhenkun
J. Plattner Jacob
F. Clark Richard
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27107953&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP970473(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/888,350 external-priority patent/US5866549A/en
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of HRP970473A2 publication Critical patent/HRP970473A2/hr
Publication of HRP970473B1 publication Critical patent/HRP970473B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cephalosporin Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR970473A 1996-09-04 1997-09-03 6-0-substituted ketolides having antibacterial activity HRP970473B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70777696A 1996-09-04 1996-09-04
US08/888,350 US5866549A (en) 1996-09-04 1997-07-03 6-O-substituted ketolides having antibacterial activity

Publications (2)

Publication Number Publication Date
HRP970473A2 HRP970473A2 (en) 1998-08-31
HRP970473B1 true HRP970473B1 (en) 2007-02-28

Family

ID=27107953

Family Applications (5)

Application Number Title Priority Date Filing Date
HR970473A HRP970473B1 (en) 1996-09-04 1997-09-03 6-0-substituted ketolides having antibacterial activity
HRP20060277AA HRP20060277B1 (hr) 1996-09-04 2006-08-11 6-0-supstituirani ketolidi antibakterijskog djelovanja
HRP20060278AA HRP20060278B1 (hr) 1996-09-04 2006-08-11 6-0-supstituirani ketolidi antibakterijskog djelovanja
HRP20060275AA HRP20060275B1 (hr) 1996-09-04 2006-08-11 6-0-supstituirani ketolidi antibakterijskog djelovanja
HRP20060276AA HRP20060276B1 (hr) 1996-09-04 2006-08-11 6-0-supstituirani ketolidi antibakterijskog djelovanja

Family Applications After (4)

Application Number Title Priority Date Filing Date
HRP20060277AA HRP20060277B1 (hr) 1996-09-04 2006-08-11 6-0-supstituirani ketolidi antibakterijskog djelovanja
HRP20060278AA HRP20060278B1 (hr) 1996-09-04 2006-08-11 6-0-supstituirani ketolidi antibakterijskog djelovanja
HRP20060275AA HRP20060275B1 (hr) 1996-09-04 2006-08-11 6-0-supstituirani ketolidi antibakterijskog djelovanja
HRP20060276AA HRP20060276B1 (hr) 1996-09-04 2006-08-11 6-0-supstituirani ketolidi antibakterijskog djelovanja

Country Status (27)

Country Link
US (4) US6028181A (cs)
EP (5) EP1291350B1 (cs)
JP (1) JP4597274B2 (cs)
KR (5) KR100523679B1 (cs)
CN (4) CN1273475C (cs)
AT (5) ATE296832T1 (cs)
BG (1) BG63547B1 (cs)
BR (1) BR9711661A (cs)
CA (1) CA2263972C (cs)
CZ (1) CZ300106B6 (cs)
DE (5) DE69733370T2 (cs)
DK (5) DK1291350T3 (cs)
ES (5) ES2242983T3 (cs)
HR (5) HRP970473B1 (cs)
HU (1) HU230166B1 (cs)
ID (1) ID19406A (cs)
IL (1) IL128681A0 (cs)
NO (1) NO314230B1 (cs)
NZ (1) NZ334274A (cs)
PL (1) PL188173B1 (cs)
PT (5) PT1291352E (cs)
RO (1) RO121473B1 (cs)
RU (1) RU2192427C2 (cs)
SI (1) SI20023B (cs)
SK (5) SK285533B6 (cs)
TR (1) TR199901127T2 (cs)
WO (1) WO1998009978A1 (cs)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495348B1 (en) 1993-10-07 2002-12-17 Regents Of The University Of Minnesota Mitomycin biosynthetic gene cluster
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
EP0952157B1 (en) 1998-04-24 2003-06-18 Pfizer Products Inc. 9A, 11B-Dehydro derivatives of 9-oxime-3-keto-6-0-methylerythromycin
US6265202B1 (en) 1998-06-26 2001-07-24 Regents Of The University Of Minnesota DNA encoding methymycin and pikromycin
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
JP4573925B2 (ja) 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2792637B1 (fr) * 1999-04-26 2001-06-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2785612A1 (fr) * 1998-11-10 2000-05-12 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
KR20010083944A (ko) * 1998-11-03 2001-09-03 실버스타인 아써 에이. 신규 마크롤라이드 항생물질
IL144542A0 (en) * 1999-03-15 2002-05-23 Abbott Lab 6-o-substituted macrolides having antibacterial activity
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
KR20020007374A (ko) 1999-04-16 2002-01-26 추후제출 매크롤라이드 항감염제
US6420535B1 (en) * 1999-06-07 2002-07-16 Abbott Laboratories 6-O-carbamate ketolide derivatives
CA2378671C (en) * 1999-06-07 2007-04-24 Abbott Laboratories 6-o-carbamate ketolide derivatives
US6417366B2 (en) * 1999-06-24 2002-07-09 Abbott Laboratories Preparation of quinoline-substituted carbonate and carbamate derivatives
US6437106B1 (en) * 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
EP1101769A3 (en) 1999-11-18 2001-10-24 Pfizer Products Inc. Nitrogen containing erythromycin derivatives
US6472372B1 (en) 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
CA2451391A1 (en) * 2001-07-03 2003-01-16 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
EP1430068A1 (en) 2001-09-17 2004-06-23 Ortho-Mcneil Pharmaceutical, Inc. 6-o-carbamate-11,12-lacto-ketolide antimicrobials
US6673774B2 (en) * 2001-12-03 2004-01-06 Enanta Pharmaceuticals, Inc. 11-O-substituted macrolides and their descladinose derivatives
IL162292A0 (en) 2001-12-05 2005-11-20 Ortho Mcneil Pharm Inc 6-O-acyl ketolide derivatives of erythromycine useful as antibacterials
CA2476223A1 (en) * 2002-02-13 2003-08-21 Abbott Laboratories Macrolide antibacterial compounds
US6831068B2 (en) * 2002-02-13 2004-12-14 Abbott Laboratories Macrolide antibacterial compounds
US20030162729A1 (en) * 2002-02-13 2003-08-28 Zhenkun Ma Macrolides with activity against methicillin-resistant staphylococcus aureus
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
US6995143B2 (en) 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6841664B2 (en) * 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US6825172B2 (en) 2002-05-31 2004-11-30 Janssen Pharmaceutica, Nv 3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents
JPWO2004078771A1 (ja) * 2003-03-07 2006-06-08 大正製薬株式会社 ２−フルオロ−６−ｏ−置換ケトライド誘導体
EP1638549A4 (en) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
US7163924B2 (en) * 2003-04-25 2007-01-16 Chiron Corporation Ketolide derivatives
US6790835B1 (en) * 2003-06-05 2004-09-14 Enanta Pharmaceuticals, Inc. Bicyclic macrolide derivatives
US20040254126A1 (en) * 2003-06-05 2004-12-16 Yao-Ling Qiu 11-12 Bicyclic erythromycin derivatives
US20050101548A1 (en) * 2003-09-12 2005-05-12 Xiaodong Lin Antimicrobial derivatives
GB0327720D0 (en) 2003-11-28 2003-12-31 Biotica Tech Ltd Erythromycins and process for their preparation
WO2005067564A2 (en) * 2004-01-07 2005-07-28 Enanta Pharmaceuticals, Inc. 6-11 bicyclic erythromycin derivatives
US7265094B2 (en) * 2004-01-09 2007-09-04 Enanta Pharmaceuticals, Inc. 9N-substituted 6-11 bicyclic erythromycin derivatives
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US20080287376A1 (en) * 2004-07-28 2008-11-20 Mohammad Salman Ketolide Derivatives as Antibacterial Agents
AU2005279050A1 (en) * 2004-07-30 2006-03-09 Centre National De La Recherche Scientifique (Cnrs) Hybrid molecules QA where Q is an aminoquinoline and A is an antibiotic residue, and the synthesis and uses thereof as antibacterial agents
FR2874922A1 (fr) * 2004-07-30 2006-03-10 Palumed Sa Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
TW200635600A (en) * 2004-12-13 2006-10-16 Enanta Pharm Inc Tetracyclic bicyclolides
EA011281B1 (ru) 2004-12-21 2009-02-27 Пфайзер Продактс Инк. Макролиды
US20060252710A1 (en) * 2005-05-04 2006-11-09 Guoqiang Wang 6-11 Bridged oxime erythromycin derivatives
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
JP5015016B2 (ja) 2006-02-07 2012-08-29 大正製薬株式会社 １０ａ−アザライド化合物
KR20090042971A (ko) 2006-08-24 2009-05-04 욱크하르트 리서치 센터 항미생물 활성을 갖는 신규한 마크로라이드 및 케토라이드
JPWO2009019868A1 (ja) 2007-08-06 2010-10-28 大正製薬株式会社 １０ａ、１２位架橋型１０ａ−アザライド化合物
KR101223158B1 (ko) * 2007-09-17 2013-01-17 이난타 파마슈티칼스, 인코포레이티드 6,11-다리걸친 바이아릴 매크로라이드
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
EP2214484A4 (en) * 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
EP2287173A4 (en) 2008-05-15 2013-06-19 Taisho Pharmaceutical Co Ltd 10A AZALIDE COMPOUND WITH 4-LOW RING STRUCTURE
ES2677007T3 (es) 2008-10-24 2018-07-27 Cempra Pharmaceuticals, Inc. Procedimientos para tratar enfermedades resistentes usando macrólidos que contienen triazol
MX2011012614A (es) 2009-05-27 2012-02-22 Wockhardt Ltd Compuestos de quetolida que tienen actividad antimicrobiana.
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
CN102724874B (zh) 2009-09-10 2018-06-01 森普拉制药公司 治疗疟疾、结核病和mac疾病的方法
KR102006200B1 (ko) 2010-03-22 2019-08-01 셈프라 파마슈티컬스, 인크. 매크로라이드의 결정 형태들 및 그 용도들
AU2011255464C1 (en) 2010-05-20 2017-02-23 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
US8796474B1 (en) 2010-08-23 2014-08-05 Rutgers, The State University Of New Jersey Macrolide compounds and methods and intermediates useful for their preparation
US9815863B2 (en) 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
KR101657751B1 (ko) 2010-12-09 2016-09-19 욱크하르트 리미티드 케토라이드 화합물
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
JP5718488B2 (ja) 2011-03-01 2015-05-13 ウォックハート リミテッド ケトライド中間体の調製方法
EP2688900B1 (en) 2011-03-22 2016-09-28 Wockhardt Limited Process for preparation of ketolide compounds
CN102766181A (zh) * 2011-05-06 2012-11-07 上海医药工业研究院 6-o-取代的红霉素衍生物的制备方法
CN102766089A (zh) * 2011-05-06 2012-11-07 上海医药工业研究院 3-(3-喹啉基)-2-丙烯-1-卤代物及其制备方法
NZ700182A (en) * 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 Ｃ−４”位置換マクロライド誘導体を含有する医薬
GB201217310D0 (en) 2012-09-27 2012-11-14 C10 Pharma As Compounds
EP2968801B1 (en) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
RU2015138797A (ru) 2013-03-15 2017-04-24 Семпра Фармасьютикалс, Инк. Конвергентные способы получения макролидных антибактериальных агентов
AR102810A1 (es) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
EP3522896A4 (en) * 2016-10-04 2020-06-17 Biopharmati SA KETOLID WITH ANTIBACTERIAL EFFECT
EP3589327A4 (en) * 2017-03-03 2022-04-06 Synovo GmbH NOVEL ANTI-INFECTION AND ANTI-INFLAMMATORY COMPOUNDS
CN109942653B (zh) * 2019-02-27 2021-06-25 北京理工大学 一种红霉素衍生物及其制备方法
CA3163337A1 (en) * 2019-12-02 2021-06-10 AliquantumRx, Inc. Salts and polymorphs of cethromycin for the treatment of disease salts and polymorphs of cethromycin
CN113817008B (zh) * 2021-07-15 2023-05-23 湖州师范学院 新型琥珀酰基十六元大环内酯的制备方法及用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
EP0553353A1 (en) * 1990-10-15 1993-08-04 Taisho Pharmaceutical Co. Ltd 2'-modified erythromycin or derivative thereof
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
EP0559896B1 (en) * 1990-11-28 1997-08-27 Taisho Pharmaceutical Co. Ltd 6-o-methylerythromycin a derivative
WO1993013663A1 (en) * 1992-01-17 1993-07-22 Abbott Laboratories Method of directing biosynthesis of specific polyketides
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
CA2093303C (en) * 1992-04-09 1998-11-24 Abraham Araya Aluminosilicates
DE69301916T2 (de) * 1992-04-22 1996-08-08 Taisho Pharmaceutical Co., Ltd., Tokio/Tokyo 5-0-desosaminylerythronolid a derivate
JP3259429B2 (ja) * 1992-04-22 2002-02-25 大正製薬株式会社 ５−ｏ−デソサミニルエリスロノライドａ誘導体
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2713226B1 (fr) * 1993-12-03 1996-01-05 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2732684B1 (fr) * 1995-04-06 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2738571B1 (fr) * 1995-09-11 1997-10-17 Roussel Uclaf Nouveaux derives de la 5-0-desosaminyl 6-0-methyl- erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
AU7447096A (en) * 1995-11-08 1997-05-29 Abbott Laboratories Tricyclic erythromycin derivatives
US6274715B1 (en) * 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
WO1998018808A1 (fr) * 1996-10-31 1998-05-07 Taisho Pharmaceutical Co., Ltd. Derives de l'erythromycine
US6171807B1 (en) * 1996-11-13 2001-01-09 Associates Of Cape Cod, Inc. Detection and quantitation of endotoxin by fluorescence polarization

Also Published As

Publication number Publication date
KR100568455B1 (ko) 2006-04-07
EP1291352A1 (en) 2003-03-12
AU729348B2 (en) 2001-02-01
DK1291351T3 (da) 2005-10-24
CN100460415C (zh) 2009-02-11
HK1021537A1 (en) 2000-06-16
ATE296832T1 (de) 2005-06-15
BR9711661A (pt) 1999-08-24
DK1291350T3 (da) 2005-09-26
EP0929563A1 (en) 1999-07-21
HU230166B1 (hu) 2015-09-28
WO1998009978A1 (en) 1998-03-12
AU4178097A (en) 1998-03-26
KR100576988B1 (ko) 2006-05-10
EP0929563B1 (en) 2005-06-01
USRE39591E1 (en) 2007-04-24
PT1291353E (pt) 2005-10-31
NO991022D0 (no) 1999-03-02
SK285533B6 (sk) 2007-03-01
KR100610043B1 (ko) 2006-08-08
RU2192427C2 (ru) 2002-11-10
IL128681A0 (en) 2000-01-31
SK286181B6 (sk) 2008-04-07
SK28699A3 (en) 2000-03-13
CA2263972A1 (en) 1998-03-12
NO314230B1 (no) 2003-02-17
DE69733723T2 (de) 2006-04-20
JP2001500855A (ja) 2001-01-23
EP1291350A1 (en) 2003-03-12
HRP20060277B1 (hr) 2014-04-11
EP1291351A1 (en) 2003-03-12
EP1291353B1 (en) 2005-06-01
DE69733369T2 (de) 2006-01-26
HRP20060277A2 (en) 2007-10-31
CZ68599A3 (cs) 1999-08-11
DE69733439T2 (de) 2006-05-04
ES2242983T3 (es) 2005-11-16
ES2242813T3 (es) 2005-11-16
KR20050044815A (ko) 2005-05-12
SI20023B (en) 2001-02-28
DE69733422T2 (de) 2006-05-04
US6028181A (en) 2000-02-22
CA2263972C (en) 2008-01-29
BG103292A (en) 1999-12-30
HRP970473A2 (en) 1998-08-31
CZ300106B6 (cs) 2009-02-11
BG63547B1 (bg) 2002-04-30
ATE296308T1 (de) 2005-06-15
HRP20060276B1 (hr) 2014-04-25
ID19406A (id) 1998-07-09
US6147197A (en) 2000-11-14
DE69733422D1 (de) 2005-07-07
DK0929563T3 (da) 2005-10-03
EP1291351B1 (en) 2005-07-13
ES2244716T3 (es) 2005-12-16
PL332009A1 (en) 1999-08-16
PL188173B1 (pl) 2004-12-31
KR20050044816A (ko) 2005-05-12
CN1237183A (zh) 1999-12-01
HRP20060278A2 (en) 2007-10-31
SK285535B6 (sk) 2007-03-01
PT1291350E (pt) 2005-09-30
PT1291351E (pt) 2005-11-30
HRP20060276A2 (en) 2007-10-31
US6075133A (en) 2000-06-13
NO991022L (no) 1999-05-03
TR199901127T2 (xx) 1999-07-21
ATE299508T1 (de) 2005-07-15
DK1291353T3 (da) 2005-10-03
CN100441591C (zh) 2008-12-10
PT1291352E (pt) 2005-09-30
CN1680420A (zh) 2005-10-12
SI20023A (sl) 2000-02-29
DE69733369D1 (de) 2005-06-30
DE69733370D1 (de) 2005-06-30
PT929563E (pt) 2005-10-31
ATE296307T1 (de) 2005-06-15
KR20050043994A (ko) 2005-05-11
KR20050043993A (ko) 2005-05-11
SK285536B6 (sk) 2007-03-01
DE69733370T2 (de) 2006-02-02
ES2242812T3 (es) 2005-11-16
KR20000068435A (ko) 2000-11-25
EP1291353A1 (en) 2003-03-12
DE69733723D1 (de) 2005-08-18
EP1291352B1 (en) 2005-05-25
RO121473B1 (ro) 2007-06-29
ATE296831T1 (de) 2005-06-15
HUP9902869A2 (hu) 2000-02-28
CN1680418A (zh) 2005-10-12
HRP20060275B1 (hr) 2014-04-11
DE69733439D1 (de) 2005-07-07
CN1273475C (zh) 2006-09-06
JP4597274B2 (ja) 2010-12-15
HRP20060278B1 (hr) 2014-04-11
HUP9902869A3 (en) 2001-04-28
SK285534B6 (sk) 2007-03-01
CN1680419A (zh) 2005-10-12
KR100523679B1 (ko) 2005-10-26
HRP20060275A2 (en) 2007-10-31
DK1291352T3 (da) 2005-09-19
EP1291350B1 (en) 2005-05-25
ES2242811T3 (es) 2005-11-16
NZ334274A (en) 2001-02-23

Similar Documents

Publication Publication Date Title
HRP970473B1 (en) 6-0-substituted ketolides having antibacterial activity
GB2381456A (en) Antimicrobial agent
EP0694558A4 (en) SPHINGOGLYCOLIPID AND USE THEREOF
HUP9901086A2 (hu) Aril-szulfonil-amino-benzol-származékok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk gyógyászati készítmények előállítására
SG49248A1 (en) Polymer-bound paclitaxel derivatives
ES2169162T3 (es) Compuestos de azetidinona sustituidos con azufre utiles como agentes hipocolesterolemicos.
CA2173150A1 (en) Novel peptide derivatives
CA2115355A1 (en) Novel tetrapeptide derivative
DE69619139D1 (de) Ein amonenaustauscherharz enthaltende tabletten
Bottalico et al. Cytochalasins: structure-activity relationships
AR015994A1 (es) Derivados de cetolidos 2-halo-6-o-sustituidos, composiciones farmaceuticas que los contienen, su uso para la manufactura de un medicamento y procesos parasu preparacion
Fujimoto et al. Squamostatin-A: unprecedented bis-tetrahydrofuran acetogenin from Annona squamosa
YU178391A (sh) Jedinjenja 7-acil-3(supstituisanih karbamoiloksi) cefema i postupak za njihovo dobijanje
GB1456674A (en) Neomycin derivatives
GB1530643A (en) Aminoglycosides
CO4960636A1 (es) Derivados de eritromicina 3-descladinosa 6-0-substituidos
IE41221L (en) Pyrazinemethanols
GB1418399A (en) Antibiotic derivatives
HK74687A (en) Azino methyl-rifamycins
GB1153304A (en) Thiodicarboxylic Esters and their use in Poly-alpha-Olefin Compositions
DE69704272D1 (de) Vitamin d analoga und verfahren zu ihrer herstellung
JPS5455047A (en) Vinyl chloride resin composition
GB2321459A (en) Synthesis of carboxylic acid derivatives
ATE196910T1 (de) 7-glykosyloxybenzopyranderivat und dieses enthaltendes antiallergisches mittel
NO922608L (no) Nye cefalosporinforbindelser og fremgangsmaater til deres fremstillin

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
PPPP Transfer of rights

Owner name: ABBVIE INC., US

ODRP Renewal fee for the maintenance of a patent

Payment date: 20160901

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20170903